Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

FRA:33L - Deutsche Boerse Ag - US5500211090 - Common Stock - Currency: EUR

401.9  +4.75 (+1.2%)

Fundamental Rating

7

Overall 33L gets a fundamental rating of 7 out of 10. We evaluated 33L against 42 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making 33L a very profitable company, without any liquidiy or solvency issues. 33L is valued quite expensive, but it does show an excellent growth. This makes 33L very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
In the past year 33L had a positive cash flow from operations.
33L had positive earnings in each of the past 5 years.
Each year in the past 5 years 33L had a positive operating cash flow.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

33L's Return On Assets of 24.50% is amongst the best of the industry. 33L outperforms 100.00% of its industry peers.
The Return On Equity of 33L (43.55%) is better than 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 30.48%, 33L belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 33L is significantly above the industry average of 11.32%.
The 3 year average ROIC (27.36%) for 33L is below the current ROIC(30.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 24.5%
ROE 43.55%
ROIC 30.48%
ROA(3y)18.95%
ROA(5y)18.12%
ROE(3y)33.12%
ROE(5y)31.09%
ROIC(3y)27.36%
ROIC(5y)24.43%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of 33L (17.05%) is better than 92.50% of its industry peers.
33L's Profit Margin has improved in the last couple of years.
33L has a Operating Margin of 23.35%. This is in the better half of the industry: 33L outperforms 80.00% of its industry peers.
33L's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 58.85%, 33L perfoms like the industry average, outperforming 47.50% of the companies in the same industry.
33L's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.35%
PM (TTM) 17.05%
GM 58.85%
OM growth 3Y5.93%
OM growth 5Y1.38%
PM growth 3Y6.4%
PM growth 5Y1.84%
GM growth 3Y1.37%
GM growth 5Y1.09%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 33L is creating value.
33L has less shares outstanding than it did 1 year ago.
33L has less shares outstanding than it did 5 years ago.
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

33L has an Altman-Z score of 13.38. This indicates that 33L is financially healthy and has little risk of bankruptcy at the moment.
33L has a Altman-Z score of 13.38. This is amongst the best in the industry. 33L outperforms 95.00% of its industry peers.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.38
ROIC/WACC3.91
WACC7.8%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.00 indicates that 33L should not have too much problems paying its short term obligations.
33L has a better Current ratio (2.00) than 75.00% of its industry peers.
33L has a Quick Ratio of 1.00. This is a normal value and indicates that 33L is financially healthy and should not expect problems in meeting its short term obligations.
33L has a better Quick ratio (1.00) than 67.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.48% over the past year.
The Earnings Per Share has been growing by 27.05% on average over the past years. This is a very strong growth
The Revenue has grown by 10.84% in the past year. This is quite good.
Measured over the past years, 33L shows a very strong growth in Revenue. The Revenue has been growing by 23.95% on average per year.
EPS 1Y (TTM)16.48%
EPS 3Y40.07%
EPS 5Y27.05%
EPS Q2Q%13.44%
Revenue 1Y (TTM)10.84%
Revenue growth 3Y29.77%
Revenue growth 5Y23.95%
Sales Q2Q%8.73%

3.2 Future

The Earnings Per Share is expected to grow by 12.26% on average over the next years. This is quite good.
Based on estimates for the next years, 33L will show a quite strong growth in Revenue. The Revenue will grow by 8.58% on average per year.
EPS Next Y14.15%
EPS Next 2Y10.46%
EPS Next 3Y10.43%
EPS Next 5Y12.26%
Revenue Next Year9.67%
Revenue Next 2Y8.3%
Revenue Next 3Y8.37%
Revenue Next 5Y8.58%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.99, the valuation of 33L can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as 33L.
The average S&P500 Price/Earnings ratio is at 28.47. 33L is around the same levels.
Based on the Price/Forward Earnings ratio of 26.64, the valuation of 33L can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 33L is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, 33L is valued rather cheaply.
Industry RankSector Rank
PE 29.99
Fwd PE 26.64
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

70.00% of the companies in the same industry are cheaper than 33L, based on the Enterprise Value to EBITDA ratio.
33L's Price/Free Cash Flow ratio is rather expensive when compared to the industry. 33L is more expensive than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.72
EV/EBITDA 17.68
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of 33L may justify a higher PE ratio.
PEG (NY)2.12
PEG (5Y)1.11
EPS Next 2Y10.46%
EPS Next 3Y10.43%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (2/4/2025, 7:00:00 PM)

401.9

+4.75 (+1.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners93.72%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap48.94B
Analysts74.76
Price Target375.46 (-6.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.06%
Min EPS beat(2)4.71%
Max EPS beat(2)5.41%
EPS beat(4)4
Avg EPS beat(4)4.57%
Min EPS beat(4)3.64%
Max EPS beat(4)5.41%
EPS beat(8)8
Avg EPS beat(8)5.58%
EPS beat(12)11
Avg EPS beat(12)5.14%
EPS beat(16)15
Avg EPS beat(16)8.54%
Revenue beat(2)0
Avg Revenue beat(2)-1.86%
Min Revenue beat(2)-3.46%
Max Revenue beat(2)-0.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-3.46%
Max Revenue beat(4)-0.26%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)5
Avg Revenue beat(12)-0.07%
Revenue beat(16)8
Avg Revenue beat(16)0.79%
PT rev (1m)1.25%
PT rev (3m)29.46%
EPS NQ rev (1m)4.21%
EPS NQ rev (3m)-3.32%
EPS NY rev (1m)0.85%
EPS NY rev (3m)2.19%
Revenue NQ rev (1m)2.42%
Revenue NQ rev (3m)-2.28%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 29.99
Fwd PE 26.64
P/S 4.97
P/FCF 31.72
P/OCF 22.43
P/B 12.69
P/tB 13.28
EV/EBITDA 17.68
EPS(TTM)13.4
EY3.33%
EPS(NY)15.09
Fwd EY3.75%
FCF(TTM)12.67
FCFY3.15%
OCF(TTM)17.92
OCFY4.46%
SpS80.9
BVpS31.67
TBVpS30.25
PEG (NY)2.12
PEG (5Y)1.11
Profitability
Industry RankSector Rank
ROA 24.5%
ROE 43.55%
ROCE 45.03%
ROIC 30.48%
ROICexc 39.33%
ROICexgc 41.13%
OM 23.35%
PM (TTM) 17.05%
GM 58.85%
FCFM 15.66%
ROA(3y)18.95%
ROA(5y)18.12%
ROE(3y)33.12%
ROE(5y)31.09%
ROIC(3y)27.36%
ROIC(5y)24.43%
ROICexc(3y)42.27%
ROICexc(5y)38.4%
ROICexgc(3y)46.02%
ROICexgc(5y)42.26%
ROCE(3y)40.41%
ROCE(5y)36.09%
ROICexcg growth 3Y11.07%
ROICexcg growth 5Y-7.81%
ROICexc growth 3Y20.21%
ROICexc growth 5Y-7.3%
OM growth 3Y5.93%
OM growth 5Y1.38%
PM growth 3Y6.4%
PM growth 5Y1.84%
GM growth 3Y1.37%
GM growth 5Y1.09%
F-Score7
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 158.75%
Cap/Sales 6.49%
Interest Coverage 250
Cash Conversion 80.73%
Profit Quality 91.88%
Current Ratio 2
Quick Ratio 1
Altman-Z 13.38
F-Score7
WACC7.8%
ROIC/WACC3.91
Cap/Depr(3y)188.88%
Cap/Depr(5y)173.01%
Cap/Sales(3y)6.99%
Cap/Sales(5y)6.66%
Profit Quality(3y)82.13%
Profit Quality(5y)80.74%
High Growth Momentum
Growth
EPS 1Y (TTM)16.48%
EPS 3Y40.07%
EPS 5Y27.05%
EPS Q2Q%13.44%
EPS Next Y14.15%
EPS Next 2Y10.46%
EPS Next 3Y10.43%
EPS Next 5Y12.26%
Revenue 1Y (TTM)10.84%
Revenue growth 3Y29.77%
Revenue growth 5Y23.95%
Sales Q2Q%8.73%
Revenue Next Year9.67%
Revenue Next 2Y8.3%
Revenue Next 3Y8.37%
Revenue Next 5Y8.58%
EBIT growth 1Y17.95%
EBIT growth 3Y37.46%
EBIT growth 5Y25.66%
EBIT Next Year30.21%
EBIT Next 3Y13.6%
EBIT Next 5Y12.01%
FCF growth 1Y1633.42%
FCF growth 3Y42.01%
FCF growth 5Y26.04%
OCF growth 1Y246.36%
OCF growth 3Y41.92%
OCF growth 5Y25.32%